trioxifene has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chedid, M; Chen, K; Goode, RL; Graff, JR; Johnson, MA; Jones, CD; Krishnan, V; Lynch, R; McNulty, AM; Neubauer, BL; Osborne, HE | 1 |
1 other study(ies) available for trioxifene and Disease Models, Animal
Article | Year |
---|---|
The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.
Topics: Adenocarcinoma; Animals; Body Weight; Cell Division; Disease Models, Animal; Estrogen Receptor alpha; Estrogen Receptor beta; Genitalia, Male; Luciferases; Lung Neoplasms; Lymphatic Metastasis; Male; Organ Size; Prostatic Neoplasms; Pyrrolidines; Rats; Receptors, Androgen; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Testis | 2003 |